课题基金 / 基金详情

ROLES OF VASCULAR AMYLOID BETA PROTEIN PRECURSOR

ROLES OF VASCULAR AMYLOID BETA PROTEIN PRECURSOR
血管淀粉样蛋白前体的作用
批准号:
2211376
负责人:
William E. Van Nostrand
金额:
$6.43万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-03-15 至 1996-02-29

项目摘要

项目成果

William E. Van Nostrand的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objectives of the proposed studies are two-fold and reflect research areas in the biochemistry, functional properties, and cell biology of PN- 2/AbetaPP that are currently funded by two research grants. First, the biochemical interactions between PN-2/AbetaPP and coagulation factors will be investigated. Specifically, the present proposal will focus on studies concerning interactions between coagulation factor X1a and PN-2/AbetaPP and the effects of high molecular weight kininogen and the effects of biologic surfaces on these interactions. In addition, characterization of the protease inhibitory and potential anticoagulant properties of a recombinant Kunitz-type protease inhibitor domain of a related AbetaPP- homolog are planned to better understand the functional relatedness of this homolog protein to PN2/AbetaPP. Second, in a somewhat different, but related and important series of studies, PN-2/AbetaPP expression and processing in cerebral blood vessels from postmortem human brain tissue and in cultured cerebrovascular smooth muscle cells will be investigated. These series of investigations will begin to elucidate how PN-2/AbetaPP may normally serve as an anticoagulant in the cerebrovasculature and how it may abnormally be involved with intracerebral hemorrhaging in patients with a rare disorder that is related to Alzheimer's disease known as hereditary cerebral hemorrhage with amyloidosis-Dutch type. Better understanding of the biochemistry and cerebrovascular cell biology of PN- 2/AbetaPP will provide insight into its normal function as well as the patho-biochemistry and pathophysiology of this protein in certain disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Gene-Edited Rat Model for Development of CAA
  • 批准号:
    10574070
  • 项目类别:
  • 资助金额:
    $45.26万
  • 财政年份:
    2022
  • 负责人:
    William E. Van Nostrand
  • 依托单位:
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)
  • 批准号:
    10435462
  • 项目类别:
  • 资助金额:
    $62.5万
  • 财政年份:
    2018
  • 负责人:
    William E. Van Nostrand
  • 依托单位:
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)
  • 批准号:
    10204132
  • 项目类别:
  • 资助金额:
    $63.46万
  • 财政年份:
    2018
  • 负责人:
    William E. Van Nostrand
  • 依托单位:
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)
  • 批准号:
    10000181
  • 项目类别:
  • 资助金额:
    $64.37万
  • 财政年份:
    2018
  • 负责人:
    William E. Van Nostrand
  • 依托单位: